Hikma Pharmaceutical | HIK - Current Assets

Stock Price
1,652.00
Daily Change
33.00 2.04%
Monthly
5.36%
Yearly
-28.05%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $2.56B in Current Assets for its fiscal semester ending in June of 2025.





Current Assets Change Date
Almirall EUR 714.05M 27.09M Jun/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Autolus Therapeutics Ltd USD 514.58M 59.67M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Orion EUR 1.34B 247.2M Dec/2025
Recordati EUR 1.71B 144.32M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024